Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers G > Headlines for Genomic Health, Inc. > News item |
JMP rates Genomic at market outperform
Genomic Health, Inc. was given a market outperform rating by JMP Securities analyst Charles C. Duncan. JPM raised its price target to $19 from $16. The company reported solid fourth-quarter financial results with positive Oncotype DX sales trajectory. Shares of the Redwood City, Calif., pharmaceutical company were down 44 cents, or 2.80%, at $15.30 on volume of 108,219 shares versus the three-month running average of 139,823 shares. (Nasdaq: GHDX)
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.